HIV Inhibitors

HIV

HIV-1

HIV-2

HIV Inhibitors, Antagonists & Activators

Product Name	HIV	HIV-1	HIV-2	Purity
Chloroquine		HIV-1		99.82%
Doxorubicin hydrochloride		HIV-1		99.90%
5-Fluorouracil	HIV			99.99%
Chloroquine phosphate		HIV-1		99.89%
Panobinostat		HIV-1
Hydroxyurea		HIV-1		≥98.0%
Plerixafor		HIV-1, EC₅₀: 1-10 nM	HIV-2, EC₅₀: 1-10 nM	98.61%
Maraviroc		HIV-1 (Ba-L), IC₅₀: 1.1 nM (in PM-1 cells)		99.88%
Ivermectin		HIV-1		98.01%
Ebselen		HIV-1		99.58%
Plerixafor octahydrochloride		HIV-1, EC₅₀: 1-10 nM	HIV-2, EC₅₀: 1-10 nM	≥98.0%
CK-666		HIV-1		99.17%
Rottlerin		HIV-1		98.09%
Betulinic acid		HIV-1, EC₅₀: 1.4 μM		98.43%
Scutellarin		HIV-1		98.56%
ONX-0914		HIV-1		99.72%
Dolutegravir		HIV-1		99.98%
Zidovudine		HIV-1		99.95%
Lopinavir		HIV-1		99.87%
Tenofovir		HIV-1		99.89%
Efavirenz		HIV-1		99.84%
Nelfinavir		HIV-1		98.83%
Raltegravir		HIV-1	HIV-2	99.93%
3-Deazaadenosine hydrochloride		HIV-1		99.67%
Emtricitabine		HIV-1	HIV-2	99.94%
Bictegravir		HIV-1		99.79%
Tenofovir Disoproxil fumarate		HIV-1		99.67%
Lenacapavir		HIV-1		98.48%
Nevirapine		HIV-1		99.93%
Stavudine		HIV-1	HIV-2	99.87%
Cenicriviroc		R5 HIV-1, IC₅₀: 0.024-0.08 nM (in PBMCs)	R5 HIV-2, IC₅₀: 0.03-0.98 nM (in PBMCs)	99.01%
TAK-779		R5 HIV-1 (CTV), EC₅₀: 3.5 nM (in PBMCs) R5 HIV-1 (CTV), EC90: 27 nM (in PBMCs) R5 HIV-1 (KK), EC₅₀: 1.6 nM (in PBMCs) R5 HIV-1 (KK), EC90: 20.8 nM (in PBMCs) R5 HIV-1 (HHA), EC₅₀: 3.2 nM (in PBMCs) R5 HIV-1 (HHA), EC90: 7.5 nM (in PBMCs) R5 HIV-1 (Ba-L), EC₅₀: 1.2 nM (in MAGI-CCR5 cells) R5 HIV-1 (Ba-L), EC₅₀: 3.7 nM (in PBMCs) R5 HIV-1 (Ba-L), EC90: 5.7 nM (in MAGI-CCR5 cells) R5 HIV-1 (Ba-L), EC90: 12.8 nM (in PBMCs)		99.73%
Limonin		HIV-1		98.68%
Triciribine		HIV-1, IC₅₀: 0.02-0.46 μM	HIV-2, IC₅₀: 0.02-0.46 μM	99.81%
Miltefosine		HIV-1		≥98.0%
Theaflavin 3,3'-digallate		HIV-1		99.73%
Cobicistat		HIV-1		99.77%
Rilpivirine		HIV-1		99.71%
Tenofovir alafenamide		HIV-1	HIV-2	99.92%
Tat-beclin 1		HIV-1		99.68%
α-Lipoic Acid		HIV-1		99.86%
Indinavir sulfate		HIV-1		99.96%
Mavorixafor trihydrochloride		HIV-1 (NL4.3 strain), IC₅₀: 1 nM (in MT-4 cells) HIV-1 (NL4.3 strain), IC₅₀: 9 nM (in PBMCs) HIV-1 (NL4.3 strain), IC90: 3 nM (in MT-4 cells) HIV-1 (NL4.3 strain), IC90: 26 nM (in PBMCs)		99.75%
5-(N,N-Hexamethylene)-amiloride		HIV-1		98.47%
Fangchinoline		HIV-1		99.92%
Elvitegravir		HIV-1	HIV-2
BRD-K98645985		HIV-1		99.19%
Darunavir		HIV-1		99.91%
Ro24-7429		HIV-1		99.90%
Sennoside A		HIV-1		99.71%
Enfuvirtide		HIV-1		99.81%
Azvudine hydrochloride		HIV-1, EC₅₀: 0.03-6.92 nM	HIV-2, EC₅₀: 0.018-0.02 nM
Etravirine		HIV-1	HIV-2	99.56%
3-Deazaadenosine		HIV-1		99.87%
Tipranavir		HIV-1		≥98.0%
Saquinavir mesylate		HIV-1	HIV-2	99.89%
Nelfinavir Mesylate		HIV-1		98.93%
Tizoxanide		HIV-1		99.09%
Sparstolonin B		HIV-1		99.54%
Pentosan Polysulfate Sodium (W/W 43%)		HIV-1
BRD-6929		HIV-1		99.04%
Temsavir		HIV-1		98.06%
Atazanavir sulfate		HIV-1		99.94%
Bromhexine hydrochloride		HIV-1		99.84%
IT1t dihydrochloride		HIV-1 (X4), IC₅₀: 14.2 nM (in MT-4 cells) HIV-1 (X4), IC₅₀: 19 nM (in PBMCs)		99.77%
Tenofovir Disoproxil		HIV-1		99.84%
Fumagillin		HIV-1		≥99.0%
PF-3450074		HIV-1 (NL4.3 strain), IC₅₀: 0.72 μM		98.44%
DDX3-IN-2	HIV			99.36%
BRD3308		HIV-1		98.82%
Obefazimod		HIV-1, IC₅₀: 0.1-0.5 μM (in PBMCs)		99.61%
Gardiquimod diTFA		HIV-1		≥99.0%
2-Hydroxyacetophenone	HIV			99.91%
Tenofovir alafenamide fumarate		HIV-1	HIV-2	99.14%
Cenicriviroc Mesylate		R5 HIV-1, IC₅₀: 0.024-0.08 nM (in PBMCs)	R5 HIV-2, IC₅₀: 0.03-0.98 nM (in PBMCs)	99.04%
Delavirdine mesylate		HIV-1		99.82%
TC14012	HIV			99.90%
Cyclotriazadisulfonamide		HIV-1		98.54%
Gardiquimod		HIV-1		99.91%
Methyl gallate		HIV-1		99.98%
9-Aminoacridine		HIV-1		99.50%
Trilobatin		HIV-1		99.00%
Oleanonic acid		HIV-1		99.63%
Atazanavir		HIV-1		99.86%
Fostemsavir		HIV-1		99.64%
L-Chicoric Acid		HIV-1		99.98%
Azvudine		HIV-1, EC₅₀: 0.03-6.92 nM	HIV-2, EC₅₀: 0.018-0.02 nM	99.60%
2-Hydroxycinnamic acid	HIV			98.30%
DAPTA		HIV-1		99.85%
Decanoyl-RVKR-CMK TFA		HIV-1	HIV-2	99.28%
2',3'-Dideoxyadenosine		HIV-1	HIV-2	99.89%
Bryostatin 1		HIV-1		99.70%
Darunavir Ethanolate		HIV-1		99.81%
Diphyllin		HIV-1, IC₅₀: 0.38 μM		99.90%
AMD 3465 hexahydrobromide		X4 HIV-1 (III_B), IC₅₀: 12.3 nM (in MT-4 cells) X4 HIV-1 (NL4.3), IC₅₀: 6.1 nM (in MT-4 cells) X4 HIV-1 (NL4.3^AMD3100), IC₅₀: 2822 nM (in MT-4 cells) X4 HIV-1 (RF), IC₅₀: 7.4 nM (in MT-4 cells) X4 HIV-1 (HE), IC₅₀: 9.8 nM (in MT-4 cells)	HIV-2 (ROD), IC₅₀: 12.3 nM (in MT-4 cells) HIV-2 (EHO), IC₅₀: 12.3 nM (in MT-4 cells)	≥98.0%
FC131 TFA	HIV			99.89%
Ibalizumab		HIV-1		99.52%
Soyasaponin II		HIV-1, IC₅₀: 112 μM		99.81%
Erythromycin Ethylsuccinate		HIV-1		≥98.0%
TAT (48-57)		HIV-1		98.65%
Celgosivir hydrochloride		HIV-1		≥98.0%
TAT peptide TFA		HIV-1		99.49%
PTACH		HIV-1		99.65%
Thiamine disulfide		HIV-1		98.05%
Apelin-12		HIV-1		99.90%
HIV-1 TAT (48-60)		HIV-1		99.80%
Tenofovir hydrate		HIV-1		≥98.0%
Bictegravir sodium		HIV-1		99.71%
TAT TFA		HIV-1		98.40%
TAK-220		HIV-1 (KK), EC₅₀: 1.2 nM (in PBMCs) HIV-1 (KK), EC90: 12 nM (in PBMCs) HIV-1 (HNK), EC₅₀: 1.7 nM (in PBMCs) HIV-1 (HNK), EC90: 28 nM (in PBMCs) HIV-1 (CTV), EC₅₀: 0.72 nM (in PBMCs) HIV-1 (CTV), EC90: 5 nM (in PBMCs) HIV-1 (HKW), EC₅₀: 1.7 nM (in PBMCs) HIV-1 (HKW), EC90: 12 nM (in PBMCs) HIV-1 (HHA), EC₅₀: 0.55 nM (in PBMCs) HIV-1 (HHA), EC90: 4 nM (in PBMCs) HIV-1 (HTN), EC₅₀: 0.93 nM (in PBMCs) HIV-1 (HTN), EC90: 15 nM (in PBMCs)		99.95%
Apelin-17(human, bovine)		HIV-1	HIV-2
Islatravir		HIV-1 (WT), EC₅₀: 0.068 nM HIV-1 (MDR), EC₅₀: 0.15 nM HIV-1 (M184V), EC₅₀: 3.1 nM		99.94%
α-Lipoic Acid-d₅		HIV-1
Vicriviroc maleate		HIV-1 (JrFL), IC90: 3.3 nM (in PBMC cells) HIV-1 (ADA-M), IC90: 2.8 nM (in PBMC cells) HIV-1 (301657), IC90: 1.8 nM (in PBMC cells) HIV-1 (JV1083), IC90: 4.9 nM (in PBMC cells) HIV-1 (RU 570), IC90: 10 nM (in PBMC cells)		99.91%
Elsulfavirine		HIV-1		99.63%
Apelin-36(human)		HIV-1	HIV-2	98.11%
BMS-378806		HIV-1	HIV-2	98.94%
NF279		HIV-1		≥98.0%
HIV-1 integrase inhibitor		HIV-1
LDC4297 hydrochloride		HIV-1 (NL4.3 strain), EC₅₀: 1.04 μM 4LIG7, EC₅₀: 1.13 μM		98.25%
Aplaviroc hydrochloride		HIV-1_Ba-L, IC₅₀: 0.4 nM HIV-1_JRFL, IC₅₀: 0.1 nM HIV-1_MOKW, IC₅₀: 0.2 nM		99.76%
Salicylanilide		HIV-1		99.90%
Chloroquine-d₅		HIV-1		≥99.0%
Censavudine		HIV-1, IC₅₀: 450-890 nM	HIV-2, EC₅₀: 30-81 nM	98.18%
3′-Azido-2′,3′-dideoxyuridine	HIV			99.11%
HIV-1 inhibitor-45		HIV-1		99.54%
Aeroplysinin 1		HIV-1, IC₅₀: 14.6 μM
Chloroquine phosphate (Standard)		HIV-1		99.67%
Hck-IN-1		HIV-1 Nef, IC₅₀: 100-300 nM		98.53%
Tenofovir alafenamide hemifumarate		HIV-1	HIV-2	99.70%
AMD 3465		X4 HIV-1 (III_B), IC₅₀: 12.3 nM (in MT-4 cells) X4 HIV-1 (NL4.3), IC₅₀: 6.1 nM (in MT-4 cells) X4 HIV-1 (NL4.3^AMD3100), IC₅₀: 2822 nM (in MT-4 cells) X4 HIV-1 (RF), IC₅₀: 7.4 nM (in MT-4 cells) X4 HIV-1 (HE), IC₅₀: 9.8 nM (in MT-4 cells)	HIV-2 (ROD), IC₅₀: 12.3 nM (in MT-4 cells) HIV-2 (EHO), IC₅₀: 12.3 nM (in MT-4 cells)	99.59%
Fostemsavir Tris		HIV-1		99.94%
Rovafovir etalafenamide		HIV-1	HIV-2
FGI-106 tetrahydrochloride		HIV-1		99.68%
Fipravirimat dihydrochloride		HIV-1
Tenofovir exalidex		HIV-1	HIV-2	98.70%
Ulonivirine		HIV-1		98.31%
Nifeviroc		HIV-1		98.17%
Ingenol-3-palmitate		HIV-1, IC₅₀: 4.1 nM		99.54%
FNC-TP		HIV-1		99.92%
Claficapavir		HIV-1		99.14%
α-Lipoic Acid (Standard)		HIV-1		99.90%
Zingibroside R1		HIV-1		99.75%
Azulene	HIV			99.98%
Kaempferol-3-O-(6′′-galloyl)-β-glucopyranoside			HIV-2	99.26%
Formycin A		HIV-1, EC₅₀: 10 μM		≥99.0%
3'-Azido-3'-deoxy-5-methylcytidine		HIV-1, EC₅₀: 0.06 μM (in PBM cells)		99.15%
SARS-CoV-IN-3		HIV-1		99.36%
Fipravirimat		HIV-1
Celgosivir		HIV-1
SARS-CoV-IN-2		HIV-1		98.66%
HIV-1 inhibitor-8		HIV-1 (WT), IC₅₀: 0.081 μM		98.03%
Reverse transcriptase-IN-1		HIV-1		98.08%
IT1t		HIV-1 (X4), IC₅₀: 14.2 nM (in MT-4 cells) HIV-1 (X4), IC₅₀: 19 nM (in PBMCs)
DPC-681		HIV-1		99.89%
Apelin-36(human) TFA		HIV-1	HIV-2	98.11%
Doxorubicin		HIV-1
Gomisin M2	HIV, EC₅₀: 2.4 μM			99.87%
Aplaviroc		HIV-1_Ba-L, IC₅₀: 0.4 nM HIV-1_JRFL, IC₅₀: 0.1 nM HIV-1_MOKW, IC₅₀: 0.2 nM
HIV-1 inhibitor-6		X4 HIV-1 (III_B), EC₅₀: 0.6 μM R5 HIV-1, EC₅₀: 0.9 μM		98.91%
FNC-TP trisodium		HIV-1
AzddMeC		HIV-1, EC₅₀: 9 nM (Human PBM cells) HIV-1, EC₅₀: 6 nM (Human macrophages)		98.96%
EFdA-TP tetraammonium		HIV-1		98.03%
EFdA-TP tetrasodium		HIV-1
Pentosan Polysulfate		HIV-1
Gomisin M1		HIV-1		99.56%
Suvizumab		HIV-1_89.6, IC₅₀: 0.2 μg/mL HIV-1_MN, IC₅₀: 0.1 μg/mL HIV-1_SF2, IC₅₀: 1.0 μg/mL
Mavorixafor		HIV-1 (NL4.3 strain), IC₅₀: 1 nM (in MT-4 cells) HIV-1 (NL4.3 strain), IC₅₀: 9 nM (in PBMCs) HIV-1 (NL4.3 strain), IC90: 3 nM (in MT-4 cells) HIV-1 (NL4.3 strain), IC90: 26 nM (in PBMCs)
KRH-3955 hydrochloride		X4 HIV-1_NL4-3, EC₅₀: 0.3-1.0 nM
Apelin-36(rat, mouse)		HIV-1	HIV-2	98.07%
FC131	HIV
NBD-557		HIV-1		99.41%
9-Propenyladenine		HIV-1
Indinavir		HIV-1
Dolutegravir intermediate-1		HIV-1		99.80%
(Z)-9-Propenyladenine		HIV-1		98.02%
Chloroquine dihydrochloride		HIV-1
Panobinostat lactate		HIV-1
Mavorixafor hydrochloride		HIV-1 (NL4.3 strain), IC₅₀: 1 nM (In MT-4 cells) HIV-1 (NL4.3 strain), IC₅₀: 9 nM (In PBMCs) HIV-1 (NL4.3 strain), IC90: 3 nM (In MT-4 cells) HIV-1 (NL4.3 strain), IC90: 26 nM (In PBMCs)
NBD-14270		HIV-1		98.47%
FGI-106		HIV-1
NBD-14189		HIV-1		99.84%
HIV-1 inhibitor-33		HIV-1 (WT), EC₅₀: 8.6 nM
HIV-1 inhibitor-51		HIV-1 (WT), IC₅₀: 0.03 μM HIV-1 (WT), Kd: 2.5 μM HIV-1 (L100I), EC₅₀: 3.04 nM HIV-1 (K103N), EC₅₀: 2.87 nM HIV-1 (Y181C), EC₅₀: 10.2 nM HIV-1 (Y188L), EC₅₀: 13.2 nM HIV-1 (E138K), EC₅₀: 9.77 nM HIV-1 (F227L+V106A), EC₅₀: 19.8 nM HIV-1 (RES056), EC₅₀: 53.3 nM
Wikstrol A		HIV-1, IC₅₀: 67.8
HIV-1 inhibitor-16		HIV-1 (WT), EC₅₀: 1.3 nM HIV-1 (K103N), EC₅₀: 5.4 nM HIV-1 (E138K), EC₅₀: 9.2 nM HIV-1 (Y181C), EC₅₀: 22 nM HIV-1 (L100I), EC₅₀: 35 mM
Siamycin I		HIV-1	HIV-2
CCR5 antagonist 3		HIV-1, EC₅₀: 0.010 μM (In TZM-bl cells)
HIV-1 inhibitor-44		HIV-1, EC₅₀: 0.209 μM
HIV-1 Nef-IN-1		HIV-1 Nef, Kd: 6.7 μM		98.60%
Kadsuracoccinic acid A		HIV-1, EC₅₀: 68.7 μM
INCB9471		HIV-1
Fuscin	HIV
H-Gly-Pro-Gly-NH2		HIV (IIIB), EC₅₀: 35 μM	HIV-2 (ROD), EC₅₀: 30 μM
BMS 561390		HIV-1 (WT), IC₅₀: 2.0 nM HIV-1 (K103N), IC₅₀: 21 nM HIV-1 (L100I), IC₅₀: 5.9 nM
HIV-1 inhibitor-34		HIV-1 (WT), EC₅₀: 6.4 nM
Fosdevirine		HIV-1 (K103N) HIV-1 (Y181C) HIV-1
HIV-1 Rev (34-50)		HIV-1
PROTAC Vif degrader-1		HIV (IIIB), EC₅₀: 33.35 μM
Reverse transcriptase-IN-3		HIV (IIIB), EC₅₀: 8 nM HIV-1 (L100I), EC₅₀: 65 nM HIV-1 (K103N), EC₅₀: 9 nM HIV-1 (Y181C), EC₅₀: 45 nM HIV-1 (Y188L), EC₅₀: 35 nM HIV-1 (E138K), EC₅₀: 0.734 μM HIV-1 (F227L+V106A), EC₅₀: 34 nM HIV-1 (RES056), EC₅₀: 42 nM
IQP-0528		HIV-1	HIV-2	99.90%
Luzopeptin A		HIV-1 RT, IC₅₀: 7 nM	HIV-2 RT, IC₅₀: 68 nM
Inophyllum B		HIV-1, IC₅₀: 1.4 μM
Corydine		HIV-1
Nevirapine-d₄		HIV-1
HIV-1 inhibitor-29		HIV (IIIB), EC₅₀: 2.18 μM HIV-1 (F227L/V106A), EC₅₀: 0.974 μM
WRNA10	HIV, IC₅₀: 10 μM (CC₅₀: 40 μM^[1])
Sennoside A (Standard)		HIV-1
HIV-1 inhibitor-64		HIV-1 (WT)
HIV-1 inhibitor-40		HIV-1 (WT), EC₅₀: 1.9 nM HIV-1 (L100I), EC₅₀: 0.019 μM HIV-1 (K103N), EC₅₀: 0.004 μM HIV-1 (Y181C), EC₅₀: 0.029 μM HIV-1 (Y188L), EC₅₀: 0.570 μM HIV-1 (E138K), EC₅₀: 0.009 μM
4'-Ethynyl-2'-deoxyadenosine		HIV-1
TC14012 TFA	HIV
AIC-292		HIV-1
HIV-IN-5		HIV-1, IC₅₀: 0.16 ± 0.0 μM HIV-1 (Y181C), IC₅₀: >100 μM HIV-1 (K103N), IC₅₀: >100 μM
HIV-1 inhibitor-13		HIV-1 (WT), EC₅₀: 2.85 ± 1.1 nM
HIV-1 inhibitor-15		HIV-1 (WT), EC₅₀: 1.7 nM HIV-1 (L100I), EC₅₀: 4 nM HIV-1 (K103N), EC₅₀: 2 nM HIV-1 (Y181C), EC₅₀: 6 nM HIV-1 (E138K), EC₅₀: 9 nM
Patentiflorin A		HIV-1
HIV-1 inhibitor-46		HIV-1, EC₅₀: 1.425 μM
HIV-1 inhibitor-39		HIV-1, EC₅₀: >112.88 μM
Emtricitabine S-oxide	HIV
HIV-1 inhibitor-30		HIV-1 (WT), EC₅₀: 40 nM RT-K103N, EC₅₀: 0.72 μM RT-Y181C, EC₅₀: 0.04 μM RT-K103N,Y181C, EC₅₀: 0.69 μM RT-L100I,K103N, EC₅₀: 0.43 μM RT-Y188L, EC₅₀: 1.42 μM RT-K103N,G190A, EC₅₀: 0.70 μM RT-K103N,V108I, EC₅₀: 0.56 μM
HIV-1 inhibitor-22		HIV-1 (WT), EC₅₀: 0.304 μM HIV-1 (K103N), EC₅₀: 0.201 μM
Myriceric acid B		HIV-1, IC₅₀: 8.3±0.2 μg/mL (infection of HIV-1 Env pseudovirus)
Dexelvucitabine		HIV-1		99.52%
CCR5 antagonist 2		HIV-1, EC₅₀: 11 nM (TZM-bl cell)
Apelin-36(rat, mouse) TFA		HIV-1	HIV-2
HIV-1 inhibitor-28		HIV-1 (WT), EC₅₀: 58 nM
AL-470		HIV-1, EC₅₀: 0.27 μM	HIV-2, EC₅₀: 0.63 μM
CCR5 antagonist 1	HIV
HIV-1 inhibitor-24		HIV-1 (WT), EC₅₀: 1.6 nM
Peptide T TFA		HIV-1
HIV-1 inhibitor-54		HIV-1
HIV-1 inhibitor-21		HIV-1 (WT), EC₅₀: 12.7 nM HIV-1 (K103N), EC₅₀: 10.4 nM
HIV-1 inhibitor-25		HIV (IIIB), EC₅₀: 13.6 nM HIV-1 (L100I), EC₅₀: 1.2458 ± 0 μM HIV-1 (K103N), EC₅₀: 0.4383 ± 0 μM HIV-1 (Y181C), EC₅₀: 0.5075 ± 0 μM HIV-1 (Y188L), EC₅₀: 5.8136 ± 2 μM HIV-1 (E138K), EC₅₀: 0.1961 ± 0 μM HIV-1 (F227L+V106A), EC₅₀: 3.0683 ± 0 μM
HIV-1 protease-IN-6		HIV-1
CXCR4 antagonist 4	HIV, IC₅₀: 7 nM
Calcium mesoxalate		HIV-1
CI-39		HIV-1 (WT), EC₅₀: 3.40 μM HIV-1 (WT), CC₅₀: >30 μM
HIV-1 inhibitor-32		HIV-1 (WT), IC₅₀: 34 nM
Atazanavir-d₁₅		HIV-1
HIV-1 protease-IN-4		HIV-1
HIV-1 inhibitor-52		HIV-1 (WT), EC₅₀: 1.6 nM HIV-1 V370A, EC₅₀: 3.0 nM HIV-1 ΔV370, EC₅₀: 5.1 nM HIV-1 V362I/V370A, EC₅₀: 2.0 nM HIV-1 T332S/V362I/prR41G, EC₅₀: 6.4 nM HIV-1 A326T/V362I/V370A, EC₅₀: 4.3 nM HIV-1 R361K/V362I/L363M, EC₅₀: 4.5 nM
HIV-1 inhibitor-18		HIV-1 NL4-3, EC₅₀: 5.14 μM
HIV-1 inhibitor-14		HIV-1 (WT), EC₅₀: 6.17 nM HIV-1 (L100I), EC₅₀: 12.4 nM HIV-1 (K103N), EC₅₀: 6.91 nM HIV-1 (Y181C), EC₅₀: 8.91 nM HIV-1 (Y188L), EC₅₀: 7.66 nM HIV-1 (F227L+V106A), EC₅₀: 5.79 nM HIV-1 (K103N+Y181C), EC₅₀: 27.9 nM HIV-1 (E138K), EC₅₀: 7.66 nM
gp120-IN-2		HIV-1, IC₅₀: 7.5 μM HIV-1, CC₅₀: 112.93 μM
HIV-1 inhibitor-23		HIV-1 (WT), EC₅₀: 24.9 nM HIV-1 (K103N), EC₅₀: 10.4 nM
Apelin-17(human, bovine) TFA		HIV-1	HIV-2
DMJ-I-228		HIV-1
Azt-pmap		HIV-1
HIV-1 inhibitor-27		HIV-1 YU2, IC₅₀: 16 μM HIV-1 NL4-3, IC₅₀: 0.5 μM HIV-1 89.6, IC₅₀: 0.39 μM
HIV-1 inhibitor-49		HIV-1 (WT), EC₅₀: 17 nM HIV-1 (L100I), EC₅₀: 0.38 μM HIV-1 (K103N), EC₅₀: 2.64 μM HIV-1 (Y181C), EC₅₀: 1.85 μM HIV-1 (E138K), EC₅₀: 0.09 μM
SAMT-247		HIV-1_IIIB, EC₅₀: 0.6 μM
CXCR4 antagonist 1		HIV-1
EFdA-TP		HIV-1
[(Cys(Bzl)84,Glu(OBzl)85)]CD4 (81-92)		HIV-1
gp120-IN-1		HIV-1, IC₅₀: 2.2 μM HIV-1, CC₅₀: 100.90 μM
α-Lipoic Acid sodium		HIV-1
Cys-TAT(47-57)		HIV-1
DENV-IN-6		HIV (IIIB)
Fozivudine tidoxil	HIV
HIV-1 inhibitor-43		HIV-1 (Y188L), EC₅₀: 21.3 nM HIV-1 (K103N+Y181C), EC₅₀: 6.2 nM HIV-1 (K103N), EC₅₀: <0.7 nM HIV-1 (Y181C), EC₅₀: <0.7 nM
Apricitabine		HIV-1
Leptomycin A		HIV-1		≥99.0%
DENV-IN-5		HIV (IIIB), EC₅₀: 0.1512 μM
ZLM-66		HIV-1 (WT), EC₅₀: 13 nM HIV-1 (K103N), EC₅₀: 13 nM HIV-1 (L100I), EC₅₀: 24 nM HIV-1 (E138K), EC₅₀: 25 nM HIV-1 (Y181C), EC₅₀: 58 nM HIV-1 (K103N+Y181C), EC₅₀: 260 nM HIV-1 (F227L+V106A), EC₅₀: 27530 nM
ICeD-2		HIV-1
HIV-1 inhibitor-41		HIV-1 (WT), IC₅₀: 20.8 nM HIV-1 (E138K), IC₅₀: 50 nM HIV-1 (L100I), IC₅₀: 1.03 μM HIV-1 (K103N), IC₅₀: 3.39 μM HIV-1 (Y181C), IC₅₀: 0.75 μM HIV-1 (Y188L), IC₅₀: 69.04 μM
UC-781		HIV-1, IC₅₀: 0.005 μM
HIV-1 capsid inhibitor 1		HIV-1, EC₅₀: 3.13 μM
12-Oxocalanolide A		HIV-1
HF50731		HIV-1, IC₅₀: 1.5 μM
Clavirolide L		HIV-1
HIV-1 inhibitor-17		HIV-1 NL4-3, EC₅₀: 2.57 μM
HIV-1 inhibitor-12		HIV-1
MIV-150		HIV-1, EC₅₀: <1 nM	HIV-2, EC₅₀: <1 nM
Atazanavir-d₁₈		HIV-1
Tat-beclin 1 TFA		HIV-1 HIV-1
MPG, HIV related		HIV-1
Indinavir sulfate ethanolate		HIV-1
Aureothin	HIV, IC₅₀: 5.3 nM
HIV-1 inhibitor-42		HIV-1, IC₅₀: 0.06 ± 0.0 μM HIV-1 (Y181C), IC₅₀: 15.510 ± 1 μM HIV-1 (K103N), IC₅₀: 53.045 ± 6 μM
Efavirenz-¹³C₆		HIV-1
Scirpusin A		HIV-1, EC₅₀: 7 μg/mL
BMS-585248		HIV-1
TAT (48-57) (TFA)		HIV-1
HIV-1 inhibitor-50		HIV-1 (WT), EC₅₀: 3.04 nM HIV-1 (L100I), EC₅₀: 3.04 nM HIV-1 (K103N), EC₅₀: 2.87 nM HIV-1 (Y181C), EC₅₀: 10.2 nM HIV-1 (Y188L), EC₅₀: 13.2 nM HIV-1 (E138K), EC₅₀: 9.77 nM HIV-1 (F227L+V106A), EC₅₀: 19.8 nM
Crotoniazide		HIV-1, EC₅₀: 11 μg/mL	HIV-2 (ROD), EC₅₀: 11 μg/mL
Stavudine sodium		HIV-1	HIV-2
beta-L-D4A		HIV-1
HIV-1 inhibitor-63		HIV-1
Tenofovir maleate		HIV-1
SDZ283-910		HIV-1
Hinnuliquinone		HIV-1
7-Deaza-2',3'-dideoxyguanosine		HIV-1		98.02%
TAT		HIV-1

Name
Email *

	Sorry, but the email address you supplied was invalid.